Prolonging deep inspiration breath-hold time to 3 min during radiotherapy, a simple solution by Vakaet, Vincent et al.
Clinical and Translational Radiation Oncology 28 (2021) 10–16Contents lists available at ScienceDirect
Clinical and Translational Radiation Oncology
journal homepage: www.elsevier .com/locate /c t roProlonging deep inspiration breath-hold time to 3 min during
radiotherapy, a simple solutionhttps://doi.org/10.1016/j.ctro.2021.02.007
2405-6308/ 2021 The Authors. Published by Elsevier B.V. on behalf of European Society for Radiotherapy and Oncology.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Abbreviations: DIBH, deep inspiration breath-hold; L-DIBH, prolonged deep
inspiration breath-hold; BMI, body mass index; FiO2, fraction of inspired oxygen;
HFNO, high flow nasal oxygen; HFPV, high Frequency Percussive Ventilation; IMRT,
intensity modulated radiotherapy; RR, respiratory rate.
⇑ Corresponding author at: University Hospital Ghent, Department of Radiother-
apy, Entrance 98, Corneel Heymanslaan 10, 9000 Ghent, Belgium.
E-mail address: vincent.vakaet@ugent.be (V. Vakaet).Vincent Vakaet a,b,⇑, Hans Van Hulle a, Max Schoepen a,c, Els Van Caelenberg d, Annick Van Greveling b,
Jeroen Holvoet b, Chris Monten a,b, Luc De Baerdemaeker d,e, Wilfried De Neve a,b, Marc Coppens d,e, Liv
Veldeman a,b
aDepartment of Human Structure and Repair, Ghent University, Belgium
bDepartment of Radiation Oncology, Ghent University Hospital, Belgium
cDepartment of Industrial Systems Engineering and Product Design, Kortrijk, Belgium
dDepartment of Anesthesia, Ghent University Hospital, Belgium
eDepartment of Basic and Applied Medical Sciences, Ghent University, Belgium
a r t i c l e i n f oArticle history:
Received 26 November 2020
Revised 17 February 2021
Accepted 17 February 2021








Pronea b s t r a c t
Background and purpose: Deep inspiration breath-hold is an established technique to reduce heart dose
during breast cancer radiotherapy. However, modern breast cancer radiotherapy techniques with lymph
node irradiation often require long beam-on times of up to 5 min. Therefore, the combination with deep
inspiration breath-hold (DIBH) becomes challenging. A simple support technique for longer duration
deep inspiration breath-hold (L-DIBH), feasible for daily use at the radiotherapy department, is required
to maximize heart sparing.
Materials and methods: At our department, a new protocol for multiple L-DIBH of at least 2 min and 30 s
was developed on 32 healthy volunteers and validated on 8 breast cancer patients during radiotherapy
treatment, using a pragmatic process of iterative development, including all major stakeholders. Each
participant performed 12 L-DIBHs, on 4 different days. Different methods of pre-oxygenation and volun-
tary hyperventilation were tested, and scored on L-DIBH duration, ease of use, and comfort.
Results: Based on 384 L-DIBHs from 32 healthy volunteers, voluntary hyperventilation for 3 min whilst
receiving high-flow nasal oxygen at 40 L/min was the most promising technique. During validation,
the median L-DIBH duration in prone position of 8 breast cancer patients improved from 59 s without
support to 3 min and 9 s using the technique (p < 0.001).
Conclusion: A new and simple L-DIBH protocol was developed feasible for daily use at the radiotherapy
center.
 2021 The Authors. Published by Elsevier B.V. on behalf of European Society for Radiotherapy and
Oncology. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).1. Introduction
Radiation treatment has an established role in breast cancer,
complementing surgery and systemic therapies to prevent recur-
rences and improve survival, both in women with node negative
and node positive disease [1]. Long term follow-up, however,shows that the beneficial effect on survival is weakened by
radiation-induced cardiac and lung cancer mortality [2,3]. The risk
is highest for left-sided breast radiation therapy and irradiation of
the internal mammary nodes, due to the proximity of the heart and
subsequent higher heart doses [4]. Deep inspiration breath-hold
(DIBH) is an established technique to reduce cardiopulmonary
doses in breast cancer irradiation treatment [5–8]. Since a deep
breath increases the distance between the target volume and the
heart [9]. Besides DIBH and heart blocks, ASTRO guidelines recom-
mend prone positioning as one of the options to reduce heart dose
[10]. Furthermore, prone position results in reduced acute and late
toxicity and lower ipsilateral lung dose [11–14]. For most radiation
treatments of the breast, the duration of beam-on time is around 1
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e.g. multi-beam intensity modulated radiotherapy (IMRT) for
whole breast with lymph node irradiation, beam-on time can be
extended to up to 5 min, especially in combination with hypofrac-
tionated schedules [15,16]. Therefore, a high number of consecu-
tive short DIBHs are required, leading to stress for the patient,
position changes and the inability of treatment in DIBH due to
exhaustion for many patients [17,18]. Also, previous research has
shown a moderate correlation between positional errors, mostly
in the superior-inferior direction, and the number of DIBHs
required, especially when treating the lymph node regions.
Three mechanisms to prolong breath-holding are well estab-
lished. Firstly, hyperventilation as a method to prolong DIBH times
is extensively used by breath-hold divers, due to inducing
hypocapnia and decreasing the CO2-drive to breath [19,20]. Sec-
ondly, pre-oxygenation increases oxygen reserve and delays the
onset of hypoxia up to 8 min [21]. Thirdly, an increase in lung infla-
tion increases breath-hold duration [22]. A combination of these
three methods has already been tested in breast cancer patients
as a technique to prolong breath-holding during radiotherapy
[23,24].
The protocol from Parkes et al. uses a mechanical ventilator for
15 min of forced hyperventilation which can increase DIBH dura-
tion to 5 min, whereas Roth et al. uses the mechanical ventilator
for 4-minutes of oxygenation followed by a one-minute period of
voluntary hyperventilation, increasing DIHB duration to 2 min
and 45 s in patients [23,24]. To our knowledge, these protocols
have not been implemented at radiotherapy departments, possibly
due to the complexity of the mechanical ventilator, the required
capital expenditure, and the high set-up time. Simpler methods
of oxygenation like high-flow nasal oxygen or an oxygen mask
have not been investigated in this context. Our goal was to develop
a simpler protocol to deliver the treatment in multiple consecutive
longer DIBHs (L-DIBHs) of at least 2 min and 30 s. We developed
the protocol on healthy volunteers; followed by a validation on
breast cancer patients after a radiotherapy session.2. Materials and methods
2.1. Volunteers and patients
The protocol was developed on 32 healthy female volunteers
and validated on 8 patients receiving curative radiotherapy for
breast cancer. All volunteers and patients gave a written informed
consent, and the study was approved by the ethics committee of
Ghent University Hospital and registered on ClinicalTrials.gov,
number NCT04091542. Eligibility criteria included women above
the age of 18 without any history of cardiac or pulmonary disease.
Exclusion criteria were currently smoking, not able to perform a
single unassisted DIBH of over 20 s, previous breath-holding expe-
rience, and WHO obesity class II (BMI > 35 kg/m2).2.2. Protocol development and validation phase
In 4 successive development cycles of 8 volunteers, the protocol
was optimized to achieve our L-DIBH target of reaching at least
2 min and 30 s based on 3 additional goals: comfort for the patient,
ease of use and the time required for set-up and patient prepara-
tion. For these criteria, no strict cut-off values were chosen but
each criterion was evaluated in a joint meeting by a group of stake-
holders including radiation oncologists, anesthesiologists, and
radiotherapy technologists. The number of cycles was not
predefined.
The 8 volunteers in each cycle were randomized to different
nests of volunteers and they performed 3 unassisted baseline11DIHBs. Each nest performed the baseline protocol as well as a
specific range of predefined variations. The first baseline protocol
was an adaptation of Roth et al. using a mechanical ventilator for
oxygenation [24]. The volunteers performed 4 different examina-
tions on 4 separate days during a working week, each time per-
forming 3 consecutive L-DIBHs and ending when they chose to
breath-out (e.g. due to discomfort). Each L-DIBH was preceded by
a preparatory phase of voluntary hyperventilation, using audio-
assistance, and oxygenation. The hyperventilation frequency was
predefined, and the volunteers were asked to breathe deeply, fol-
lowing the tempo. Prior to the first examination the volunteers
did not receive any preparatory instructions, except for informa-
tion on the types of oxygenation devices used during their exami-
nations. During each examination, the vital parameters of the
volunteer were monitored using a Carescape B650 anesthesia
monitor (GE Healthcare, Finland). Unfortunately, high flow nasal
oxygen does not allow for EtCO2 measurements within clinically
acceptable levels of accuracy [25]. When the level of hypocapnia
cannot monitored by an accurate measurement of EtCO2 during
hyperventilation, the examiner looked for signs of hypocapnic
tetany. The hyperventilation phase was stopped by the examiner
if any of those signs were noted. The full details of an examination
and the safety criteria can be found in Appendix A. After each
examination of 3 consecutive L-DIBHs the side effects and comfort
of the technique were evaluated using patient questionnaires
(Appendix B).
Throughout the cycles, the following parameters were opti-
mized: oxygenation device, duration of hyperventilation, hyper-
ventilation frequency (RR), fraction of inspired oxygen (FiO2); L-
DIBH position and flow rate (L/min) both during hyperventilation
and breath-holding. The following three oxygenation devices,
ordered by higher ease of use and lower set-up time, were investi-
gated (Fig. 1): 1) mechanical ventilator (Leon Plus, Löwenstein,
Germany) and a face mask (Series 6700, Hans Rudolph, USA) in
pressure support ventilation at 25 mbar peak pressure, 2) High-
flow nasal oxygen or HFNO (Optiflow Thrive, Fisher & Paykel,
New Zealand), 3) non-rebreathing mask with oxygen reservoir
(Ecolite, Intersurgical, UK), also called a Hudson mask. The follow-
ing hyperventilation frequencies were examined (in breaths/min-
ute): 12, 16, 20 and volunteer choice. For the mechanical
ventilator or HFNO, a maximum FiO2 of 80% was allowed to reduce
the risk of absorption atelectasis [26].
After 4 development cycles, the stakeholders decided that the
protocol met all preset requirements and was ready to be validated
on a group of 8 patients. They were examined on 4 days after a
radiotherapy session for breast cancer, and they performed 3 con-
secutive L-DIBHs on each day. These examinations were not part of
their curative radiotherapy treatment.2.3. Statistical analysis
Study data were collected and managed using REDCap elec-
tronic data capture tools hosted at Ghent University Hospital. All
analyses and data visualizations were done with R-studio (version
3.6.2). During protocol development median and corresponding
interquartile range (IQR) for L-DIBH durations, and, the comfort
and pain assessments were compared pairwise using the Wilcoxon
rank sum test within the same subject. The non-parametric Fried-
man test was used to compare median breath-hold durations, dur-
ing the validation phase. A two-sided significance level of 0.05 was
chosen.
Fig. 1. Oxygenation methods tested during protocol development. A. High-flow
nasal oxygen (Optiflow Thrive device), delivery of a heated and humidified oxygen
mixture through a nasal cannula. B. Mechanical ventilator with facemask. C. Non-
rebreather mask with oxygen reservoir or Hudson mask.
Table 1







n= 32 8 40
Baseline characteristics
Age, years 43 (34–51) 56 (41–60) 44 (36–54)






Weight, kg 63 (57–63) 62 (59–69) 62 (58–70)
BMI 22 (21–24) 24 (22–27) 23 (21–25)
Current alcohol use 23 (72%) 7 (88%) 30 (75%)
Former smoker 8 (25%) 3 (38%) 11 (28%)
Medication use 19 (59%) 7 (88%) 26 (65%)
Comorbidities
Thyroid disease 0 (0%) 3 (38%) 3 (8%)
Diabetes 0 (0%) 0 (0%) 0 (0%)
Back pain 12 (38%) 5 (63%) 17 (43%)
Shoulder pain 4 (13%) 3 (38%) 7 (18%)
Cancer treatment
Previous chemotherapy 6 (75%)
Hormonal therapy 3 (38%)
Baseline examination
















Diastolic blood pressure –
mmHg
68 (61–78) 72 (63–89) 68 (62–78)
Heart rate - BPM 67 (60–77) 68 (62–74) 67 (61–77)
Respiratory rate - /min 12 (10–16) 17 (12–25) 12 (10–16)
Data are median (IQR) or number (%). Some percentages do not total 100 because of
rounding.
BMI body mass index, BPM beats per minute, RT: radiotherapy
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123. Results
From March 2019 until December 2019 a total of 32 healthy
volunteers were included in the development phase, and 8 patients
in the validation phase. Baseline characteristics of the volunteers
and patients can be found in Table 1. Unassisted DIBH times were
1 min and 2 s for the volunteers and 59 s for the patients. Table 2
contains a summary of the most common volunteer and patient
reported side effects during and after the examinations.3.1. Protocol development
A summary of median L-DIBH durations can be found in Table 3.
In total 390 L-DIBHs were performed and 21 L-DIBHs were miss-
ing: 12 L-DIBHs due to involuntary breathing of a single volunteer,
3 due to claustrophobia when putting on the ventilator mask, 2
because of mask leakage, 2 due to incorrectly following the instruc-
tions on the first try, and 2 because of a technical issue. A total of
369 L-DIBHs were used for the optimization of the protocol.3.1.1. First cycle
The first cycle focused on the difference between a mechanical
ventilator and HFNO (Fig. 1A & B). No significant difference was
found in median L-DIBH duration (p = 0.2) between both oxygena-
tion devices. Since there were no differences in median L-DIBH
duration or comfort, but HFNO has a shorter set-up time and is
easier in use, the stakeholders decided to continue using HFNO.
Other parameters were investigated in smaller nests of 2 volun-
teers. Increasing the duration of hyperventilation from 2 min to
6 min resulted in a 1 min and 40 s longer median L-DIBH duration.
Based on these results, the stakeholders decided to investigate 3
Table 2
Overview of side effects both during the examination and after ending the examination.
Side effects during examination Side effects after examination
Number of examinations n = 160 Number of examinations n = 160
Did you feel any? Do you now feel any?
Tingling feeling in fingers/feet or limbs 40 (25%) Dizziness 20 (13%)
Pain 25 (16%) Fatigue 16 (10%)
Need to cough 21 (13%) Do you now have?
Dizziness 16 (10%) Dry mouth 41 (26%)
Table 3
Median L-DIBH durations of the volunteers in m:ss (Interquartile range m:ss – m:ss) in all the comparisons made during the iterative development.
N* Standard protocol mm:ss (IQR) P-valuey mm:ss (IQR) Alternative protocol
Cycle 1
8 Mechanical ventilator 3:25 (2:47 – 3:53) 0.2 3:39 (2:39 – 4:10) High Flow Nasal Oxygen
2 2 min of hyperventilation 3:12 (2:36 – 4:31) N/A 4:52 (4:10 – 5:44) 6 min of hyperventilation
2 Supine position 3:40 (2:51 – 4:09) N/A 3:08 (2:32 – 3:38) Prone position
2 16 breaths/minute during hyperventilation 3:36 (3:11 – 3:55) N/A 3:13 (2:44 – 4:00) 20 breaths/minute during hyperventilation
2 60% fraction of inspired oxygen 2:55 (2:26 – 3:43) N/A 2:48 (1:54 – 3:07) 80% fraction of inspired oxygen
Cycle 2
8 High Flow Nasal Oxygen 2:58 (2:00 – 3:40) 0.001 2:37 (1:44 – 3:13) Hudson mask
4 3 min of hyperventilation 2:52 (2:14 – 3:28) 0.2 3:02 (2:23 – 3:47) 5 min of hyperventilation
4 Supine position 2:57 (1:31 – 3:46) 0.3 2:36 (1:37 – 3:21) Prone position
Cycle 3
8 3 min of hyperventilation 3:28 (2:40 – 4:28) 0.002 3:09 (2:34 – 3:51) 2 min of hyperventilation
8 16 breaths/minute during hyperventilation 3:28 (2:40 – 4:28) 0.2 3:24 (2:40 – 4:20) 12 breaths/minute during hyperventilation
8 40L/minute flow during hyperventilation 3:28 (2:40 – 4:28) 0.001 2:59 (2:19 – 4:03) 20L/minute flow during hyperventilation
Cycle 4
8 16 breaths/minute during hyperventilation 2:53 (2:00 – 4:00) 0.2 3:42 (1:49 – 4:18) Volunteer choice during hyperventilation
8 60% fraction of inspired oxygen 2:53 (2:00 – 4:00) <0.001 2:13 (1:23 – 2:43) 21% fraction of inspired oxygen
8 20L/minute flow during L-DIBH 2:53 (2:00 – 4:00) 0.3 3:36 (2:30 – 4:04) 0L/minute flow during L-DIBH
* Number of volunteers in the comparison y Wilcoxon signed rank test within a volunteer performing the baseline and alternative protocol  P-values not shown due to the
small number of subjects investigated (N = 2)
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the second cycle.
3.1.2. Second cycle
The second research cycle investigated whether oxygenation
using a simple Hudson mask (Ecolite, Intersurgical, UK) is equal
to HFNO (Fig. 1A & C). Median L-DIBH duration was 22 s longer
using HFNO (p = 0.002), and both methods scored similarly on
comfort. Since set-up time is not shorter with a Hudson mask,
the stakeholders decided on further using HFNO. Longer hyperven-
tilation, above 3-minutes, did not result in longer L-DIBH duration.
3.1.3. Third and fourth cycle
Decreasing hyperventilation time from 3min back to 2 min, sig-
nificantly decreased median L-DIBH duration by 19 s (p = 0.002).
Normal air decreased the L-DIBH duration by 40 s (p < 0.001).
Reducing the flow rate to 20 L/min. during hyperventilation, signif-
icantly decreased L-DIBH durations with 29 s (p = 0.001). After the
third and fourth cycle no major changes to the protocol were made
compared with the second cycle and the protocol was accepted by
the stakeholders for validation in breast cancer patients.
3.2. Validation phase
The final protocol that was validated on 8 breast cancer patients
after a radiotherapy session uses 3 min of hyperventilation at 16
breaths/min with pre-oxygenation using HFNO (FiO2 of 60%;
40 L/min. during hyperventilation and 20 L/min. during breath-
hold), in prone position. Median L-DIBH duration improved from
59 s (IQR 41 s: 1 min 8 s) without support to 3 min and 9 s (in-
terquartile range (IQR) 2 min 6 s: 3 min 45 s) using the protocol13(p < 0.001). As seen in Fig. 2, median L-DIBH times were signifi-
cantly better for each consecutive L-DIBH attempt during a single
examination (Friedman test, p < 0,001) at 2:25 (IQR 1:49 – 3:03),
3:18 (IQR 2:04 – 3:55) and 3:35 (IQR 2:44 – 4:30), for the first, sec-
ond and third attempt respectively. On each consecutive day, the
median total L-DIBH duration of the three attempts increased sig-
nificantly (Friedman test, p = 0,001) at 7:43 (IQR 4:24 – 9:19) on
the first day, 8:16 (IQR 6:52 – 9:03) on the second day, 10:09
(IQR 9:19 – 11:18) on the third day, and 11:50 (IQR 9:16 –
12:09) on the final day.4. Discussion
We developed a protocol, feasible to use at a radiotherapy
department, using the combination of voluntary hyperventilation
and oxygenation. Validation on 8 breast cancer patients showed
that this technique can prolong the DIBH duration of at least
2 min and 30 s (Fig. 2), both in prone and supine position. This
should permit most treatment plans to be delivered in a single L-
DIBH, unlike the current delivery using multiple short DIBHs
[15,27]. Furthermore, up to 3 consecutive L-DIBHs are achievable,
thus permitting more extensive treatments or cone-beam CT
(CBCT) using L-DIBH. Also, fewer DIBHs should minimize intrafrac-
tion motion [17]. Our protocol could be especially important for
plans that include the internal mammary nodes, which have aver-
age delivery times of 7 min and 30 s with IMRT requiring a very
high number of 30 s DIBHs [16].
Prolonging breath-hold using a combination of deep inspiration,
hyperventilation and pre-oxygenation has previously been investi-
gated in breast cancer patients using a mechanical ventilator
(Fig. 1B) [23,24]. We compared pressure support mechanical ven-
Fig. 2. Boxplots of the L-DIBH durations during validation with 8 breast cancer patients a) according to the day of the examination or b) according to the order of L-DIBHs
during each examination day. The box shows the upper and lower quartile, showing the interquartile range (IQR). The line dividing the box represents the median. The upper- and
lower whiskers represent the upper and lower values within 1.5 times the IQR. The dots represent the outliers outside 1.5 times the IQR above the upper quartile and bellow the lower
quartile.
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No differences in L-DIBH durations were observed, but HFNO has
several advantages. Firstly, ease of use is higher compared to the
mechanical ventilator. As described by Parkes et al., the ventilator
parameters need to be adapted to the volunteer [28], and this
requires training for appropriate operation. Secondly, set-up of
the mechanical ventilator takes significantly longer and is prone
to failure since an air-tight fit of the face mask is essential [29].
Thirdly, the HFNO system with nasal cannula is perceived as less
claustrophobic and preferred by most of the volunteers. Schwab-
bauer et al. also showed HFNO is more comfortable and preferred
by patients with acute hypoxic respiratory failure [30]. We also
compared HFNO to a Hudson mask (Fig. 1A & C) for pre-
oxygenation. HFNO enables around 20 s longer median L-DIBH
durations.
We propose a 3-minute period of voluntary hyperventilation
before L-DIBH. This is similar to the preoxygenated hyperventi-
lated hypocapnic apnea-induced radiation (PHAIR) protocol [24],
but considerably shorter than the protocol of Parkes et al. [23] In
the PHAIR protocol, volunteers were asked to perform 1 min of
hyperventilation after 4 min of oxygenation, resulting in slightly
shorter L-DIBH duration compared with our protocol. However,
our protocol has a shorter preparation time, allows consecutive
L-DIBHs and does not require a mechanical ventilator. It seems that
most of the effect of hyperventilation is reached after 3 min.
Besides the large individual differences, we found that the duration
of the preparation phase had the most impact on L-DIBH duration.
Further prolonging hyperventilation probably leads to longer L-
DIBH duration due to more profound hypocapnia, as also shown
by Parkes et al. reaching durations over 5 min with 15 min of
preparation. But longer preparation is time-consuming and there-
fore difficult to implement in the daily routine of a radiotherapy14department. Even with our technique, the setup and on-couch time
will probably still be longer than with repeated short breath holds.
The technique is unnecessary for most breast radiotherapy treat-
ments, which have a beam-on time of around 1 to 2 min, but the
aim of this research is to find a solution for complex treatments
[15]. Future research on individual adaptation of the hyperventila-
tion duration, based on patient training results and treatment char-
acteristics, could minimize overall treatment time and success rate
in daily practice. Another solution to further decrease time slots,
would involve shortening of the preparation time following the
first L-DIBH. Parkes et al. found that after thorough preparation,
a short 1-minute break can allow an equally long second L-DIBH,
compared to the first L-DIBH [31]. Further research is necessary
to confirm these finding using our technique.
Other techniques have been developed to prolong DIBH dura-
tion in breast cancer, not using hyperventilation and oxygen. High
Frequency Percussive Ventilation (HFPV) was developed for
unanesthetized patients with lung or breast cancer. Very long
apnea is achievable using HFPV, with 3 patients reaching single
apnea durations of over 7 min [32,33]. However, adaptation to
the individual patient is necessary and a leak-free seal, crucial to
prevent motion drift due to air leakage. Finally, a mechanical ven-
tilator can be used to change breathing patterns and reduce motion
variability of the tumor [28,34,35]. This approach requires both an
airtight face mask and expertise in mechanical ventilation at the
radiotherapy department. In contrast to all previous techniques,
our protocol is simple, requires minimal set-up time and equip-
ment and limited training.
The volunteers and patients could easily perform 3 consecutive
L-DIBHs with only a minimal resting-time in-between 2 L-DIBHs
and this during 4 successive sessions. Important to note, is the abil-
ity for patients to perform this technique in prone, since the com-
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[9,36]. Hyperventilation has been known to cause symptoms of
dizziness, tingling and lightheadedness [37,38]. No serious adverse
events were observed, besides a grade 2 laryngitis in an immuno-
compromised patient. L-DIBH duration increases with each succes-
sive breath-hold during a single examination session, and
progressively throughout the 4 sessions, which highlights the pos-
sible benefit of a training phase before using the technique during
radiotherapy treatment [39]. Our L-DIBH durations could poten-
tially be further increased by using visual feedback in addition to
audio guidance [40,41] and by instructing patients to perform
home practice [42,43]. The proposed protocol was developed and
validated in 32 volunteers and 8 patients, who were all highly
motivated and presenting with low comorbidity.
The actual adoption of our protocol in daily practice still
requires additional research, including imaging studies to deter-
mine the L-DIBH reproducibility, intra- and interfraction motion
and planning margins, and the development for a training program
for patients. In general, patients are highly motivated to perform a
DIBH during breast cancer radiotherapy, resulting in a high rate of
compliance, and we found the same to be true of the volunteers
and patients during our L-DIBH examinations [6,7,39]. Especially
in patients which can only hold their breath for a short duration,
support by our technique could result in better confidence. All par-
ticipants understood the technique, they could execute it well and
felt satisfied afterwards. During the examinations we focused on
creating a safe and repeatable environment with clear and simple
instructions, since previous research has shown this improves the
patient experience [18,39]. To create this environment, appropriate
monitoring of the patients is required. Our research utilized anes-
thesia grade equipment, but since no severe adverse events were
captured, further reduction in monitoring equipment to pulse
oximetry is probably safe, lowering the capital costs to implement
the technique [23].
In conclusion, HFNO combined with a short period of voluntary
hyperventilation significantly prolongs DIBH durations, allowing
for treatments with multiple consecutive L-DIBHs of at least
2 min and 30 s.
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